SKIBSTED RUSSELL

CIK 00013081059 companiesVERO BEACH, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001308105

Recent Transactions

33 trades

Purchase
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2026-06-30$1.93/sh+3,277→ 16,689 total
Purchase
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2026-06-15$2.22/sh+2,654→ 13,412 total
Purchase
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2026-05-29$2.57/sh+2,292→ 10,758 total
Purchase
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2026-05-15$2.97/sh+1,984→ 8,466 total
Purchase
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2026-04-30$2.69/sh+2,190→ 6,498 total
Purchase
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2026-04-15$2.97/sh+1,984→ 4,308 total
Purchase
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2026-03-31$2.54/sh+2,324→ 2,324 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2025-10-01+108,000→ 108,000 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Stock Options (Right to Buy)
2025-10-01+324,000→ 324,000 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2025-07-24+1,775,044→ 1,803,044 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2024-07-16+28,000→ 28,000 total
Award
ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
2023-11-21+50,000→ 50,000 total
Award
ALIMERA SCIENCES INC
Common Stock
2023-03-26+58,000→ 75,500 total
Award
ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
2023-01-09+52,500→ 52,500 total
Award
ALIMERA SCIENCES INC
Common Stock
2023-01-09+17,500→ 17,500 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Stock Option (Right to Buy)
2022-09-09+80,000→ 80,000 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Stock Option (Right to Buy)
2020-09-15+600,000→ 600,000 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Stock Option (Right to Buy)
2020-09-15+150,000→ 150,000 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-12-18$1.03/sh−7,781→ 24,078 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-12-18+22,500→ 31,859 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2018-12-18−22,500→ 11,250 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-10-04+11,250→ 13,250 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2018-10-04−11,250→ 33,750 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-10-04$2.22/sh−3,891→ 9,359 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2018-03-15+150,000→ 150,000 total
Purchase
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-08-23$2.64/sh+2,000→ 2,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2017-06-06+250,000→ 250,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2016-09-08+50,000→ 50,000 total
Award
AEOLUS PHARMACEUTICALS, INC.
Non-qualified Stock Option (right to buy)
2013-03-08+150,000→ 150,000 total
Purchase
AEOLUS PHARMACEUTICALS, INC.
Common Stock
2012-05-23$0.24/sh+7,027→ 17,027 total
Purchase
AEOLUS PHARMACEUTICALS, INC.
Common Stock
2011-05-18$0.41/sh+5,000→ 5,000 total
Purchase
AEOLUS PHARMACEUTICALS, INC.
Common Stock
2011-05-18$0.43/sh+10,000→ 10,000 total
Award
Talon Therapeutics, Inc.
Employee Stock Option (Pursuant to Rule 16b-3; right to buy)
2005-07-25+150,000→ 150,000 total

Companies

Recent Filings

Address

C/O PROCESSA PHARMACEUTICALS, INC. 601 21ST STREET SUITE 300

VERO BEACH, FL, 32960

View on SEC.gov